Feb 27 |
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
|
Feb 27 |
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Feb 27 |
Minerva falls as FDA rejects schizophrenia therapy
|
Feb 27 |
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
|
Feb 27 |
Minerva schizophrenia drug rejected by FDA
|
Feb 22 |
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
|
Nov 7 |
Minerva Neurosciences GAAP EPS of -$1.03 misses by $0.26
|
Nov 7 |
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
|
Oct 20 |
12 Best Performing Biotech Stocks in 2023
|